Wedbush Morgan Downgrades Discovery Laboratories (DSCO) to Sell
Wedbush Morgan downgrades Discovery Laboratories Inc. (Nasdaq: DSCO) from Hold to Sell, after Sufaxin program discontinued and capital restraints remain an issue.
Discovery Laboratories, Inc., a biotechnology company, engages in developing surfactant replacement therapies (SRT) to treat respiratory disorders and diseases.
Related Categories
DowngradesStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
